Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of transcranial direct current stimulation and varenicline in smokers with major depressive disorder
IRCT20221214056816N1Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of varenicline in nicotine dependence, major depressive disorder (MDD), anxiety disorder and 1 more, sponsored by Zanjan University of Medical Sciences. Primary endpoints: Executive function, Cravings and 3 more. Started Feb 2023; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependencemajor depressive disorder (MDD)anxiety disordertrauma and stressor-related disorders
Beyond the preview
Go deeper on IRCT20221214056816N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221214056816N1.